ISIN | IE00BD8GP507 |
---|---|
Valorennummer | 39040681 |
Bloomberg Global ID | WGHCNUC ID |
Fondsname | Wellington Management Funds (Ireland) plc - Wellington Global Health Care Equity Fund CHF N AccU |
Fondsanbieter |
Wellington Management Company LLP
Web: https://www.wellingtonfunds.com |
Fondsanbieter | Wellington Management Company LLP |
Vertreter in der Schweiz |
BNP Paribas, Paris, Zurich Branch Zürich |
Distributor(en) | Wellington Global Administrator, Ltd. |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | Equity Health Care |
Anteilskategorie | Accumulation |
Domizilland | Irland |
Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide. |
Besonderheiten |
Aktueller Preis * | 11.17 CHF | 12.11.2024 |
---|---|---|
Vorheriger Preis * | 11.25 CHF | 08.11.2024 |
52 Wochen Hoch * | 12.02 CHF | 16.07.2024 |
52 Wochen Tief * | 9.62 CHF | 29.11.2023 |
NAV * | 11.17 CHF | 12.11.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 1'953'743'872 | |
Anteilsklassevermögen *** | 456'014 | |
Trading Information SIX |
YTD-Performance | +11.05% |
29.12.2023 - 12.11.2024
29.12.2023 12.11.2024 |
---|---|---|
1 Monat | -1.80% |
15.10.2024 - 12.11.2024
15.10.2024 12.11.2024 |
3 Monate | -1.52% |
12.08.2024 - 12.11.2024
12.08.2024 12.11.2024 |
6 Monate | -0.72% |
13.05.2024 - 12.11.2024
13.05.2024 12.11.2024 |
1 Jahr | +15.52% |
13.11.2023 - 12.11.2024
13.11.2023 12.11.2024 |
2 Jahre | +6.77% |
14.11.2022 - 12.11.2024
14.11.2022 12.11.2024 |
3 Jahre | -6.23% |
12.11.2021 - 12.11.2024
12.11.2021 12.11.2024 |
5 Jahre | +11.65% |
05.02.2020 - 12.11.2024
05.02.2020 12.11.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 8.90% | |
---|---|---|
UnitedHealth Group Inc | 7.18% | |
Novo Nordisk A/S | 5.18% | |
AstraZeneca PLC | 4.53% | |
Merck & Co Inc | 4.44% | |
Danaher Corp | 2.82% | |
Boston Scientific Corp | 2.66% | |
Novartis AG Registered Shares | 2.57% | |
Intuitive Surgical Inc | 2.37% | |
argenx SE | 2.35% | |
Letzte Daten-Aktualisierung | 30.09.2024 |
TER | 1.33% |
---|---|
Datum TER | 15.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.25% |
Ongoing Charges *** | 1.32% |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |